Article
Chemical inhibition of RPA gap protection sensitizes BRCA1-deficient cancers to PARP inhibition
2025-04-15
Abstract excerpt
Poly (ADP-ribose) polymerase inhibitors (PARPi) are standard of care for many BRCA1 deficient cancers, though few cures are achieved. We sought to determine if targeting the protection of the single-strand DNA gaps induced by PARPi in BRCA-deficient cancers could increase efficacy. Replication protein A (RPA) participates in critical protein-protein and protein-DNA interactions to protect single-stranded DNA (ssDN...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32e1e6ea-b75c-5708-9f13-d247f093972e
- DOI
- 10.1101/2025.04.09.647957
